Study Quality Must Be Considered When Evaluating Long-term Outcomes of Antenatal Corticosteroid Therapy in Children-Reply
JAMA Pediatr
.
2022 Oct 1;176(10):1049.
doi: 10.1001/jamapediatrics.2022.2858.
Authors
Kiran Ninan
1
2
,
Kellie E Murphy
3
,
Sarah D McDonald
1
2
4
5
Affiliations
1
Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ontario, Canada.
2
Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
3
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada.
4
Department of Radiology, McMaster University, Hamilton, Ontario, Canada.
5
Division of Maternal-Fetal Medicine, McMaster University, Hamilton, Ontario, Canada.
PMID:
35969385
DOI:
10.1001/jamapediatrics.2022.2858
No abstract available
Publication types
Comment
MeSH terms
Adrenal Cortex Hormones* / therapeutic use
Child
Female
Gestational Age
Humans
Pregnancy
Premature Birth*
Prenatal Care
Substances
Adrenal Cortex Hormones